Cambridge [UK], August 6 (ANI): Implantable insulin-releasing devices show potential as an alternate method of treating diabetes without insulin injections or cannula insertions. However, one barrier that has precluded their usage so far is that the immune system attacks them after implantation, generating a thick layer of scar tissue that limits insulin release.
\
\
